Latest Connective tissue diseases Stories
High Rate of Inactivity Among People with Arthritis in all States ATLANTA, Dec. 8, 2011 /PRNewswire-USNewswire/ -- People with arthritis are significantly more likely to be physically inactive than those without the disease despite the proven benefits of physical activity for arthritis management, cites new CDC data released today. According to the Arthritis Foundation, the study underscores the need to address arthritis-specific barriers and to expand the reach of effective...
ANAHEIM, Calif., Dec. 6, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Oppenheimer Healthcare Conference to be held on December 13-14, 2011 in New York. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Tuesday, December 13, 2011 at 2:45 p.m. ET. A live webcast and subsequent archived replay of the presentation will be accessible at...
HAYWARD, Calif., Dec. 1, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus. After analysis by an independent statistician, data from the on-going PEARL-SC study indicate that weekly and monthly subcutaneous doses of blisibimod resulted in...
ATLANTA, Nov. 30, 2011 /PRNewswire/ -- UCB, Inc., a leading biopharmaceutical company focused on immunology treatments and research, today announced the 30 recipients of the 2011 UCB Rheumatoid Arthritis Family Scholarship. This scholarship recognizes outstanding individuals from across the country who are pursuing higher education as part of their efforts to live beyond the limitations of rheumatoid arthritis. "UCB is dedicated to go beyond making a difference in the lives of...
In a nationwide study based on data from the in-patient register, researchers have studied the risk of a blood clot on the lung for patients with autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease and type 1 diabetes. The study showed that 31 of the 33 autoimmune diseases studied were associated with an increased risk of pulmonary embolism – a blood clot on the lung. Autoimmune diseases, in which the immune system attacks the body, are fairly common. Thyroid...
ANAHEIM, Calif., Nov. 22, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Piper Jaffray Healthcare Conference to be held on November 29-30, 2011 in New York. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, November 30, 2011 at 8:00 a.m. ET. A live audio only webcast and...
THOUSAND OAKS, Calif., Nov. 22, 2011 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement: Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel(®) (etanercept). This patent is owned by Hoffman-La Roche Inc. ("Roche") and exclusively licensed to Amgen. Immunex Corporation (acquired by Amgen in 2002) originally licensed this patent application from Roche in 1999, and in 2004, Amgen paid Roche a one-time payment and obtained...
SEOUL, South Korea, Nov. 22, 2011 /PRNewswire/ -- The efficacy on intravenous infusion of adipose-derived mesenchymal stem cells was studied by researchers from five different countries--South Korea, United States, Japan, China, and Germany. These findings were reported in the Journal of Translational Medicine, titled: "Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells." Dr. Jeong Chan...
Among patients with moderate to severe psoriasis, treatment options that are most compatible with their personal and professional life appear to be most important, and treatment location appears more important than probability and magnitude of treatment outcome, according to a report in the November issue of Archives of Dermatology, one of the JAMA/Archives journals. "As a chronic debilitating inflammatory disease of the skin and joints, psoriasis can cause considerable physical...
Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: inflammatory arthritis and autoimmune disease. Because of these findings, researchers say women should be encouraged to continue taking the medication to gain its full benefit. The study is published online Nov. 11 in the journal Breast Cancer Research and Treatment. Preliminary findings were presented in 2010 at the 74th Annual Scientific Meeting of the...
